Meperidine Hydrochloride/Promethazine Hydrochloride

盐酸哌替啶/盐酸异丙嗪

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeperidine Hydrochloride/Promethazine Hydrochloride
Drug Alias Name哌替啶异丙嗪Meperidine Hydrochloride and Promethazine HydrochlorideMeperidine/Promethazine盐酸异丙嗪/盐酸哌替啶Promethazine/Meperidine +[14] 
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonistsOpioid receptors agonists
TargetsOpioid receptorsHistamine H1 receptor
Therapy Area/IndicationsSedationPainAnesthesia
Global Approved IndicationsSedationPainAnesthesia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1961/11/13
Country/TerritoryUnited States
CombinationsYes Meperidine HydrochloridePromethazine Hydrochloride
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesWest-Ward Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHikma Pharmaceuticals Plc
Active IndicationsN/A
Inactive IndicationsSedationPainAnesthesia

Other Information

ATC CodeN/A
Related LinksN/A